ING Groep NV Raises Stake in Corteva, Inc. $CTVA

ING Groep NV raised its position in Corteva, Inc. (NYSE:CTVA) by 74.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 83,780 shares of the company’s stock after acquiring an additional 35,863 shares during the quarter. ING Groep NV’s holdings in Corteva were worth $5,616,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CTVA. Drummond Knight Asset Management Pty Ltd purchased a new stake in shares of Corteva during the 4th quarter worth approximately $25,713,000. Alberta Investment Management Corp purchased a new stake in shares of Corteva during the 3rd quarter worth approximately $5,018,000. Avior Wealth Management LLC lifted its position in shares of Corteva by 464.7% during the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock worth $2,205,000 after buying an additional 27,075 shares during the last quarter. HighTower Advisors LLC lifted its position in shares of Corteva by 8.6% during the 3rd quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock worth $12,352,000 after buying an additional 14,436 shares during the last quarter. Finally, Arbejdsmarkedets Tillaegspension purchased a new stake in shares of Corteva during the 4th quarter worth approximately $23,679,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of CTVA opened at $76.04 on Tuesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a market capitalization of $50.86 billion, a P/E ratio of 44.73, a P/E/G ratio of 2.36 and a beta of 0.57. The company’s fifty day moving average is $81.03 and its two-hundred day moving average is $75.09. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. Corteva’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is 42.35%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of several recent analyst reports. The Goldman Sachs Group boosted their price objective on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Mizuho upped their price target on shares of Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, April 15th. Finally, Citigroup upped their price target on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.